Welcome to
Gilead Medical Information

This site is an online medical resource that provides access to scientific information about Gilead products and related information. The information provided is not intended to be and should not be understood to provide medical advice.

Choose an option that describes you:

By clicking “I’m a US healthcare professional”, you’re acknowledging that you’re a healthcare professional practicing in the US. This site is an educational resource for US healthcare professionals and may include products or uses that have not been approved by the US Food and Drug Administration.

WCLC 2025

WCLC 2025
September 06-09, 2025
Barcelona, Spain

World Conference on Lung Cancer.

Explore more information for Gilead Oncology therapies

Material Type

Poster

Filter by Keyword(s)

Results (1)

A Phase 3 Study of Sacituzumab Govitecan in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer

Author(s): Dowlati A

trodelvy
Oncology
Sacituzumab

View Poster

Welcome to Gilead Medical Information

Choose an option that describes you:

WCLC 2025

Filter results with keywords such as:

A Phase 3 Study of Sacituzumab Govitecan in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer

Chat

Medical Inquiry

Meeting Request

You are leaving this website

Welcome to
Gilead Medical Information